Some products are only avaliable in certain regions. Set your region reference. North America|Global
9th May 2022
New York, May 6, 2022 – As the war in Ukraine enters its third month, journalists facing increased risks in their daily reporting will receive lifesaving medical supplies through a new partnership between the Committee to Protect Journalists and the medical device company Medtrade, the manufacturer of CELOX Hemostatic Technology. The medical supplies,...
17th March 2022
Medtrade Products Ltd are proud to announce the success of receiving the MDR certification for the CELOX CE range of devices alongside MDR Quality Management system certification from BSI. The EU MDR is a medical device regulation that affects all medical devices placed in the European market. Medtrade the parent company...
11th December 2020
Despite significant developments in scientific understanding and technology, hemorrhage remains the leading cause of preventable trauma related deaths in civilian life and on the battlefield.1-3 The challenges medics face when treating a patient is being unaware of the patients internal conditions through, for example, the use of blood thinners. Another...
Electra House,
Crewe Business Park,
Crewe,
UK,
CW1 6GL
Tel: +44 (0)1270 500019
Email: info@celoxmedical.com
New York – SoHo – Hudson Square,
101 Avenue of the Americas,
8th and 9th Floors,
New York, USA,
NY 10013
Tel: +1 646 417 8452
Email: info@omni-stat.com
This website uses Cookies to improve your browsing experience and to help with our marketing. You can read more about removing Cookies here: Cookie Policy
I'm fine with this